Drug Shortage Report for RIVASTIGMINE
Report ID | 244195 |
Drug Identification Number | 02417022 |
Brand name | RIVASTIGMINE |
Common or Proper name | RIVASTIGMINE |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | RIVASTIGMINE |
Strength(s) | 6MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N06DA |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2025-07-31 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2024-11-29 |
Company comments | Looking to transfert to another supplier |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2024-11-29 | English | Compare |
v2 | 2024-11-29 | French | Compare |
Showing 1 to 2 of 2